UBS analyst Justin Lake has hiked his earnings estimates for Medicare insurer HealthSpring. But Lake, who has a 'buy' rating on the company, is sticking to his $52 price target, which still leaves the stock (Ticker: HS) about 40 percent of upside.
Morgan Keegan researcher Rob Mains says Brookdale Senior Living shares also can still climb more than 40 percent, but isn't in a hurry to jump in. In a note reiterating his 'outperform' rating, Mains says the stock (Ticker: BKD) may remain cheap "for a few months."
And over at Hilliard Lyons, analysts have launched coverage of Clarcor shares with a 'buy' rating and a $54 price target. That makes the firm the most optimistic on the Street about Clarcor (Ticker: CLC), which is changing hands at roughly $44 today.
POSTDATA: WARRANTY DEEDS